X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (875) 875
Book Chapter (784) 784
Patent (83) 83
Publication (4) 4
Reference (2) 2
Conference Proceeding (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (318) 318
life sciences & biomedicine (312) 312
humans (282) 282
hematology (219) 219
middle aged (183) 183
aged (175) 175
male (174) 174
female (164) 164
adult (162) 162
aged, 80 and over (131) 131
oncology (129) 129
prognosis (109) 109
beer (83) 83
biochemistry (83) 83
chemistry (83) 83
compositions or test papers therefor (83) 83
condition-responsive control in microbiological orenzymological processes (83) 83
enzymology (83) 83
measuring or testing processes involving enzymes, nucleicacids or microorganisms (83) 83
metallurgy (83) 83
microbiology (83) 83
mutation or genetic engineering (83) 83
processes of preparing such compositions (83) 83
spirits (83) 83
vinegar (83) 83
wine (83) 83
mutation (80) 80
adolescent (79) 79
leukemia, myeloid, acute - genetics (79) 79
chromosome aberrations (70) 70
physics (70) 70
cytogenetics (63) 63
investigating or analysing materials by determining theirchemical or physical properties (61) 61
measuring (61) 61
testing (61) 61
genetics & heredity (59) 59
abridged index medicus (56) 56
karyotyping (55) 55
leukemia (54) 54
young adult (54) 54
acute myeloid leukemia (48) 48
in situ hybridization, fluorescence (44) 44
acute disease (41) 41
genetic aspects (40) 40
analysis (36) 36
translocation, genetic (36) 36
myelodysplastic syndromes - genetics (35) 35
cancer (32) 32
cohort studies (32) 32
immunophenotyping (32) 32
leukemia, myeloid - genetics (31) 31
survival rate (31) 31
hemic and lymphatic diseases (30) 30
leukemia, myeloid, acute - diagnosis (30) 30
survival analysis (30) 30
gene expression profiling (29) 29
remission induction (29) 29
gene expression (27) 27
leukemia, myeloid, acute - mortality (27) 27
biomarkers, tumor - genetics (26) 26
polymerase chain reaction (26) 26
genetic research (25) 25
leukemia, myeloid, acute - pathology (25) 25
follow-up studies (24) 24
mutation - genetics (24) 24
disease-free survival (23) 23
leukemia, myelogenous, chronic, bcr-abl positive - genetics (23) 23
fms-like tyrosine kinase 3 - genetics (22) 22
hematology, oncology and palliative medicine (22) 22
oncogene proteins, fusion - genetics (22) 22
antineoplastic agents - therapeutic use (21) 21
myeloproliferative disorders - genetics (21) 21
nuclear proteins - genetics (21) 21
oligonucleotide array sequence analysis (20) 20
research (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
chromosome deletion (19) 19
dna mutational analysis (19) 19
neoplasm proteins - genetics (19) 19
treatment outcome (19) 19
child (18) 18
diagnosis (18) 18
leukemia, lymphocytic, chronic, b-cell - genetics (18) 18
minimal residual disease (18) 18
myelodysplastic syndromes - diagnosis (18) 18
chromosome banding (17) 17
cytogenetic analysis (17) 17
flow cytometry - methods (17) 17
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (17) 17
myelodysplastic syndrome (17) 17
myelodysplastic syndromes - pathology (17) 17
reverse transcriptase polymerase chain reaction (17) 17
risk factors (17) 17
aml (16) 16
dna-binding proteins - genetics (16) 16
flow cytometry (16) 16
fusion proteins, bcr-abl - genetics (16) 16
genes (16) 16
imatinib mesylate (16) 16
medicine & public health (16) 16
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2000 - 2008
Journal Article
Nature (London), ISSN 1476-4687, 09/2011, Volume 478, Issue 7367, pp. 64 - 69
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2011, Volume 364, Issue 24, pp. 2305 - 2315
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 02/2014, Volume 32, Issue 5, pp. 415 - 423
Purpose Deep molecular response (MR4.5) defines a subgroup of patients with chronic myeloid leukemia (CML) who may stay in unmaintained remission after... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Piperazines - administration & dosage | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Young Adult | Benzamides - administration & dosage | Time Factors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Aged, 80 and over | Adult | Female | Benzamides - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Pyrimidines - administration & dosage | Risk Factors | Proportional Hazards Models | Treatment Outcome | Imatinib Mesylate | Piperazines - adverse effects | Remission Induction | Cytarabine - administration & dosage | Disease Progression | Interferon-alpha - administration & dosage | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Fusion Proteins, bcr-abl - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Fusion Proteins, bcr-abl - antagonists & inhibitors | Pyrimidines - adverse effects | Aged | Fusion Proteins, bcr-abl - metabolism | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 04/2011, Volume 29, Issue 12, pp. 1634 - 1642
Journal Article